Workshop summary
The use of pharmacotherapies for smoking cessation during pregnancy
Neal L Benowitza, Delia A Dempseyb, Robert L Goldenbergc, John R Hughesd, Patricia Dolan-Mullene, Paul L Ogburnf, Cheryl Onckeng, C Tracy Orleansh, Theodore A Slotkini, H Pennington Whiteside Jrc, Sumner Yaffej
a Departments of
Medicine, Psychiatry, and Biopharmaceutical Sciences, University of
California-San Francisco, San Francisco, California, USA, b Department of Pediatrics, University of
California-San Francisco, c Smoke-Free
Families Program, Department of Obstetrics and Gynecology, University
of Alabama at Birmingham, Birmingham, Alabama, USA, d Department
of Psychiatry, University of Vermont, Burlington, Vermont, USA, e Center for Health Promotion
Research and Prevention, University of Texas-Houston Health Science
Center, School of Public Health, Houston, Texas, USA, f Department of Obstetrics and
Gynecology, Mayo Medical School, Rochester, Minnesota, USA, g Department
of Medicine, University of Connecticut Health Center, Farmington,
Connecticut, USA, h Research and
Evaluation Unit, The Robert Wood Johnson Foundation, Princeton, New
Jersey, USA, i Department of
Pharmacology & Cancer Biology, Duke University Medical Center, Durham,
North Carolina, USA, j Center for Research on Mothers
and Children, National Institute for Child Health and Human
Development, Bethesda, Maryland, USA
Correspondence to: H Pennington Whiteside, Jr, MSPH, Smoke-Free Families National Program Office, University of Alabama at Birmingham, School of Medicine, Department of Obstetrics and Gynecology, 320 CIRC, 1530 3rd Avenue South, Birmingham, AL 35294-0021, USA; hpw@uab.edu
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
A workshop entitled "The use of pharmacotherapies for smoking cessation during pregnancy", sponsored by the National Institute of Child Health and Human Development (NICHD) and the Robert Wood Johnson Foundation (RWJF), was held in Rockville, Maryland, on 19 May 1999. The goals of the workshop were: (1) to determine the current state of knowledge related to the use of pharmacotherapies for smoking cessation during pregnancy; and (2) to outline a research agenda to determine the effectiveness and safety of these pharmacotherapies. Attending the workshop were many of the academic experts working in this area in the USA and representatives from NICHD, RWJF, the National Cancer Institute (NCI), the National Institute of Drug Abuse (NIDA), the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the American College of Obstetrics and Gynecology (ACOG), the Society for Research on Nicotine and Tobacco (SRNT), and several pharmaceutical companies.
| |
Background |
|---|
In the USA,
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Orleans, C T., Barker, D. C, Kaufman, N. J, Marx, J. F
(2000). Helping pregnant smokers quit: meeting the challenge in the next decade. Tobacco Control
9: 6i-11
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
